Evidence map›Paper›PMID 21092279›Full record

ArticleBMC cancer2010

Evaluation of FTIR spectroscopy as a diagnostic tool for lung cancer using sputum.

Paul D Lewis, Keir E Lewis, Robin Ghosal, Sion Bayliss, Amanda J Lloyd, John Wills, Ruth Godfrey, Philip Kloer, Luis A J Mur

Registry-linked trialAbstract readEvaluation Study
In one paragraph

Article in BMC cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00899262 (Early Detection of Lung Cancer), which is not on this map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00899262 unknown statusnot on this map

Early Detection of Lung Cancer: Metabolic Biomarkers for High Risk Screening (MEDLUNG)

TypeobservationalSponsorSouth West Wales Cancer InstituteRan2008Enrolled300ConditionsLung Cancer, Tobacco Use DisorderArmsimmunohistochemistry staining method, laboratory biomarker analysis, sputum cytology, Fourier transform infrared spectroscopy, diagnostic bronchoscopy
3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas.International journal of molecular sciences · 2024
    Review
  10. The Influence of the Nature of the Polymer Incorporating the Same AInternational journal of molecular sciences · 2023
    Article
  11. Review
  12. Liquid biopsies: the future of cancer early detection.Journal of translational medicine · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul D LewisSwansea University, UK. p.d.lewis@swansea.ac.uk
Keir E Lewis
Robin Ghosal
Sion Bayliss
Amanda J Lloyd
John Wills
Ruth Godfrey
Philip Kloer
Luis A J Mur

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurvival time for lung cancer is poor with over 90% of patients dying within five years of diagnosis primarily due to detection at late stage. The main objective of this study was to evaluate Fourier transform infrared spectroscopy (FTIR) as a high throughput and cost effective method for identifying biochemical changes in sputum as biomarkers for detection of lung cancer.

methodsSputum was collected from 25 lung cancer patients in the Medlung observational study and 25 healthy controls. FTIR spectra were generated from sputum cell pellets using infrared wavenumbers within the 1800 to 950 cm-1 "fingerprint" region.

resultsA panel of 92 infrared wavenumbers had absorbances significantly different between cancer and normal sputum spectra and were associated with putative changes in protein, nucleic acid and glycogen levels in tumours. Five prominent significant wavenumbers at 964 cm-1, 1024 cm-1, 1411 cm-1, 1577 cm-1 and 1656 cm-1 separated cancer spectra from normal spectra into two distinct groups using multivariate analysis (group 1: 100% cancer cases; group 2: 92% normal cases). Principal components analysis revealed that these wavenumbers were also able to distinguish lung cancer patients who had previously been diagnosed with breast cancer. No patterns of spectra groupings were associated with inflammation or other diseases of the airways.

conclusionsOur results suggest that FTIR applied to sputum might have high sensitivity and specificity in diagnosing lung cancer with potential as a non-invasive, cost-effective and high-throughput method for screening.

trial registrationClinicalTrials.gov: NCT00899262.

Indexed as

High-Throughput Screening AssaysSpectroscopy, Fourier Transform InfraredAgedBiomarkers, TumorCase-Control StudiesClinical Trials as TopicFemaleHumansLung NeoplasmsMaleMass ScreeningMiddle AgedPredictive Value of TestsPrincipal Component AnalysisSensitivity and SpecificitySputumBiomarkers, Tumor

Identifiers

PMID21092279
PMCPMC3000851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.